Skip to Content
Request Appointment
Clinical Trials
Patient Portal
Cancer Care
Providers
Locations
About
Request Appointment
Find
A Phase II randomized study of adjuvant immunotherapy with the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab versus Pembrolizumab only after complete resection of high-risk cutaneous melanoma
Phase II Clinical Trial
Indication:
Melanoma
Trial Number:
03897881
Trial Status:
OPEN
Learn more about this clinical trial.
Participating Locations